27.07.2013 Views

Rapport: "Embryonale stamceller". - Teknologirådet

Rapport: "Embryonale stamceller". - Teknologirådet

Rapport: "Embryonale stamceller". - Teknologirådet

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Embryonale</strong> stamceller – høring om anvendelse af stamceller i forskning og behandling 23. januar 2003<br />

Lars U. Wahlberg<br />

M.D., Ph.D., Executive Vice President and COO.<br />

Dr. Lars Wahlberg graduated with a Bachelor of Science in biophysics from University of Houston in 1980,<br />

and an MD in 1985 from the University of Texas Health Science Center at San Antonio, Texas, USA and<br />

trained in neurosurgery, neuroscience, and biomaterials at Brown University, USA and the Karolinska<br />

Institute, Sweden leading to his specialty boards in neurosurgery and his Ph.D. He received additional<br />

training in stereotactic neurosurgery from 1991 to 1992 at the Karolinska Hospital, Sweden, followed by a<br />

chief resident position and faculty appointment in neurosurgery at Brown University, USA. Dr. Wahlberg<br />

left Brown University in 1994 as an Assistant Professor of Medicine. From 1994 to 1997, Dr. Wahlberg<br />

served as Assistant Professor at Karolinska Institute, where he in addition to his clinical responsibilities<br />

did basic and applied research on cell encapsulation and neural stem cells. Dr. Wahlberg joined Cyto-<br />

Therapeutics, Inc. in 1997 to apply encapsulated and neural stem cells in neurosurgery. The cell encapsulation<br />

technology was invented, developed and patented by Dr. Aebischer, Dr. Wahlberg, and colleagues<br />

(while at Brown U.). In 1999, Dr. Wahlberg moved to Denmark and teamed up with Dr. Teit E. Johansen<br />

and Prof. Anders Björklund to spin-off a new biotechnology company, NsGene A/S, dedicated to develop<br />

cell- and gene-based therapies for neurological diseases. NsGene was established from a successful gene<br />

therapy research program at NeuroSearch A/S. Dr. Wahlberg is the COO of NsGene and is responsible for<br />

the R&D activities. In addition, Dr. Wahlberg is the coordinator of a recently awarded 2.9 million EU<br />

grant surrounding the development of human dopaminergic neurons using neural stem cells and progenitors.<br />

Peter Øhrstrøm<br />

53 år. Cand.scient. 1972.<br />

Lic. phil. i idehistorie 1980.<br />

Dr. scient. i videnskabshistorie & -teori 1988.<br />

Ansat ved Institut for Kommunikation, Aalborg<br />

Universitet, 1986 - siden 2001 som professor.<br />

Medlem af Det Etiske Råd 2000.<br />

113

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!